Effects of the Thai Herbal Wattana Formula and Its Ingredients in the Human Hepatocarcinoma HepG2 Cells: Safety and Efficacy Considerations
2
Issued Date
2025-10-01
Resource Type
ISSN
1934578X
eISSN
15559475
Scopus ID
2-s2.0-105018774470
Journal Title
Natural Product Communications
Volume
20
Issue
10
Rights Holder(s)
SCOPUS
Bibliographic Citation
Natural Product Communications Vol.20 No.10 (2025)
Suggested Citation
Booranasubkajorn S., Lumlerdkij N., Chaisri S.M.A.T.M., Akarasereenont P., Prieto Garcia J.M. Effects of the Thai Herbal Wattana Formula and Its Ingredients in the Human Hepatocarcinoma HepG2 Cells: Safety and Efficacy Considerations. Natural Product Communications Vol.20 No.10 (2025). doi:10.1177/1934578X251385040 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/112699
Title
Effects of the Thai Herbal Wattana Formula and Its Ingredients in the Human Hepatocarcinoma HepG2 Cells: Safety and Efficacy Considerations
Author's Affiliation
Corresponding Author(s)
Other Contributor(s)
Abstract
Introduction: The Thai Herbal Wattana formula (WNF) is a multi-ingredient remedy used to promote overall health and mitigate age-related physiological degeneration, suggesting a potential adjuvant use in oncological treatments. Aims: This ethnopharmacological study aimed to evaluate cytotoxic and antimigratory effects of the Ayurveda Siriraj WNF AVS073 variation (ASW) and its active/s botanical constituents in human liver cancer (HepG2) cells. Methods: ASW and its ingredients were evaluated for cytotoxicity (Alamar blue), anti-migratory activity (2D gap closure). Mechanistic studies included cell death, apoptosis and cell cycle arrest (flow cytometry), and intracellular glutathione levels. Bioguided isolation was used to identify the active compound/s. Results: ASW did not inhibit HepG2 cell proliferation at 200 µg/mL although it halved intracellular glutathione levels and reduced cell migration similarly to paclitaxel 0.01 nM. In contrast, the water extract from Biancaea sappan (syn. Caesalpinia sappan L.) (CSL) was the only ingredient showing cytotoxicity (IC50 = 44 µg/ml). It induces apoptosis and G2/M phase cell cycle arrest and significantly reduced 2D cell migration without modifying glutathione levels. Brazilein was dereplicated as the active cytotoxic component in CSL but it did not show any effect on glutathione levels or 2D cell migration. Conclusion: This preclinical study demonstrates that the ASW formula lacks direct in vitro cytotoxicity towards HepG2 cells, but effectively reduced cell mobility and intracellular glutathione although at non-physiological concentrations. B. sappan L., exhibits potent cytotoxic and anti-migratory activities. Brazilein is its primary cytotoxic compound although is not endowed with the glutathione-depleting or anti-migratory effects observed in the ASW formula. These findings suggest that ASW's benefits in oncology may primarily link up with its established immunological and anti-inflammatory effects, while its lack of toxicity to HepG2 cells, a proxy for hepatocytes, plus its clinically proven lack of major adverse effects might indicate a positive safety profile.